Detalles de la búsqueda
1.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol;
10(4): 439-447, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451530
2.
Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report.
Case Rep Oncol Med;
2024: 1566299, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361964
3.
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report.
Case Rep Oncol;
16(1): 372-377, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384199
4.
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial.
Cancer Sci;
114(8): 3342-3351, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139543
5.
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Cancer Med;
12(10): 11525-11541, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999734
6.
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study.
Eur J Cancer;
185: 83-93, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966696
7.
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).
Clin Lung Cancer;
24(4): 371-375, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849264
8.
Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension.
BMC Pulm Med;
22(1): 449, 2022 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36443763
9.
Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer.
Eur J Cancer;
160: 227-234, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862083
10.
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).
Sci Rep;
11(1): 23140, 2021 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848786
11.
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial.
Eur J Cancer;
149: 14-22, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33813328
12.
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).
Lung Cancer;
156: 12-19, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872943
13.
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.
Respir Med Case Rep;
32: 101364, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33665078
14.
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).
Clin Lung Cancer;
22(2): 147-151, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199228
15.
Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma.
Respir Med Case Rep;
31: 101170, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32714828
16.
A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).
Lung Cancer;
138: 65-71, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31654836
17.
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC.
Cancer Res;
79(17): 4439-4452, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31273063
18.
Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
Clin Lung Cancer;
20(4): e531-e533, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164318
19.
Response of BRAFV600E-Mutant Lung Adenocarcinoma With Brain Metastasis and Leptomeningeal Dissemination to Dabrafenib Plus Trametinib Treatment.
J Thorac Oncol;
14(5): e97-e99, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31027751
20.
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS.
Cancer Cell;
34(3): 439-452.e6, 2018 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30205046